Navigation Links
Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines

CALGARY, April 17, 2007 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") announces that a poster by Dr. Maureen E. Lane et al. of , New York, entitled "In Vivo Synergy between Oncolytic Reovirus and Gemcitabine in Ras-Mutated Human HCT116 Xenografts" is scheduled to be presented today at the American Association for Cancer Research (AACR) Annual Meeting in Los Angeles, CA. The meeting runs from April 14-18, 2007.

The researchers found that treatment of human colon cancer cell lines with the combination of REOLYSIN(R) and gemcitabine resulted in both in vitro and in vivo synergy. There was no toxicity associated with the combined treatment. Tumours treated with the combination were significantly smaller (by area and weight) than tumours in control groups or tumours treated with either agent alone. The researchers concluded that the synergistic combination of REOLYSIN(R) and gemcitabine is a promising therapeutic regimen for study in clinical trials.

"It is rare to see the virtual elimination of tumours as well as the long-lasting therapeutic effect that we have observed from this study," said Dr. Brad Thompson, President and CEO of Oncolytics. "We are very encouraged by these results and look forward to testing this particular treatment combination in our upcoming human systemic administration trial in the U.K."

The poster will be available on the Oncolytics website today at www.oncolyticsbiotech.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about
'"/>




Page: 1 2 3

Related medicine technology :

1. Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial
2. Oncolytics Biotech Inc.s Research Collaborators to Present REOLYSIN Clinical Trial Data at ASCO Conference
3. Oncolytics Biotech Inc. Collaborators to Present Reovirus/Gemcitabine Combination Research at AACR Annual Meeting
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
8. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
9. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
10. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
11. Prana Biotechnology Presents New Key Findings on PBT2
Post Your Comments:
(Date:6/18/2013)... -- Actavis, Inc. (NYSE: ACT ) today announced that ... and Exchange Commission (SEC) a registration statement on Form S-4 ... plc (NASDAQ: WCRX ), which included a ... (the "Form S-4"). As previously announced on May ... into a definitive agreement pursuant to which Actavis will acquire ...
(Date:6/18/2013)... GARDEN CITY, N.Y. , June 18, 2013 ... announced that it has entered into an exclusive ... and Mid-Atlantic regions with eWellness Corporation ("EWC") for ... "An easy to use physical therapy program ... of diabetes and cardiovascular disease," said Chris ...
(Date:6/18/2013)... , June 18, 2013  Women are frequently the ... unfortunately they often do not give the same priority ... kept information from their doctor because they were too ... to a recent survey conducted by Allergan and endorsed ... to bringing education, funding and research to the field ...
Breaking Medicine Technology:Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9
... 8, 2011 A state-of-the-art, eFlow Technology nebulizer (PARI ... and spirits. Mias (Mee-us), a 27-year-old orangutan, has what ... disease that is a substantial problem in both wild ... in orangutans may also have some similarities to cystic ...
... The MED Group, a Managed Health Care Associates, Inc. ... solutions company focused on Home Medical Equipment providers is ... National Orthotics and Prosthetics Network.  Tim Pederson (formerly of ... be leading the development of The MED Group,s National ...
Cached Medicine Technology:Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 2Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 3Denver Zoo Orangutan Breathes Easier With eFlow Technology From PARI 4The MED Group Launches the New National Orthotics & Prosthetics Network 2
(Date:6/18/2013)... Cheap Concert Tickets has released additional inventories ... gets underway in July. Soccer fans can add code ... , The popularity and hype of soccer has ... the hype of the game triggered the sports-minded citizens of ... the veins of fans from the Caribbean. The adrenalin ...
(Date:6/18/2013)... June 18, 2013 Daily Gossip Magazine has ... reviews and useful articles. , The magazine has decided ... to a new anabolic recipe every week . ... is the perfect guide for readers who are looking to ... at Daily Gossip reveals that anabolic food is almost entirely ...
(Date:6/18/2013)... 18, 2013 As obesity rates sky rocket ... for surgical equipment during childbirth comes as no shock. Forceps ... the mother when she is unable to do so herself ... associated with higher rates of complication for both the mother ... to the mother and child, forceps births add to the ...
(Date:6/18/2013)... SEATTLE, WA—A Washington state resident filed a ... he fell ill with a hepatitis A infection after ... The complaint was filed in Snohomish County Superior ... law firm that has filed 14 previous lawsuits ... Brian Brothers consumed “Townsend Farms Organic Antioxidant Blend” on ...
(Date:6/18/2013)... The Drug Delivery Partnering Terms and Agreements ... drug delivery partnering deals and agreements entered into by ... provides a detailed understanding and analysis of how and ... of deals are discovery or development stage whereby the ... license the license drug delivery technology. These deals tend ...
Breaking Medicine News(10 mins):Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4
... that is at the origin of brain tumors known as oligodendrogliomas, ... the most common type of malignant brain tumor. In a ... Cancer Cell , investigators found that the tumor originates in and ... are often referred to as "daughter" cells of stem cells. The ...
... out by the University of Granada (UGR) warns of the ... the different autonomous communities to improve recycling and waste disposal. ... law that the Spanish Ministry of the Environment and Rural ... "We carried out a comparison of the clinical waste management ...
... -- A newly published case history highlights the importance of ... report details a situation involving a stray dog found in ... in March 2010. When it was later learned that the ... animal shelter records and a public notification to identify people ...
... and generic drug manufacturers have long been at odds over regulations ... make use of valuable clinical trial data. A new ... is the first to calculate the financial and social costs of ... term of exclusive access will lead to higher drug costs in ...
... CHICAGO (January 6, 2011) According to a report published ... American College of Surgeons , surgery residents improved their knowledge ... of a Web-based curriculum. The expectation is for residents ... context and system of health care, as well as the ...
... thousands of synthetic molecules to fish for disease-specific antibodies, researchers ... a simple blood test. The same methodology might lead to ... in the January 7th issue of the journal Cell ... Alzheimer,s disease, it suggests it is a pretty general platform ...
Cached Medicine News:Health News:Researchers pinpoint origin of deadly brain tumor 2Health News:Clinical waste management needs specialized regulation 2Health News:How do data exclusivity periods affect pharmaceutical innovation? 2Health News:Web-based curriculum improves surgical residents' knowledge of health care business 2Health News:A blood test for Alzheimer's disease? 2Health News:A blood test for Alzheimer's disease? 3
... an elastic belt to help lift the weight ... Apron features "all around protection to cover you ... wearing and removing a breeze. For additional back ... - they reduce pressure on the vertebrae and ...
... Wrap Apron has always been a ... to put-on, adjust and take-off. Our ... The new Easy sures Wrap features ... fit more easily. The attached Thyroid ...
... Medtronic Electrodes are made of ... The exposed tip of the ... serves as the recording area. ... available. Each needle is pre-sterilized ...
... The Triage BNP Test is ... Blood test measuring B-type natriuretic peptide ... heart ventricles in response to ventricular ... hormonal marker of ventricular systolic and ...
Medicine Products: